rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-7-11
|
pubmed:abstractText |
Rhenium-186 ((186)Re) and rhenium-188 ((188)Re) are promising radionuclides for the inhibition of restenosis after percutaneous transluminal angioplasty or other vascular interventions. Until now the maximal dose tolerance of endothelial cells has not been clearly known.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1432-086X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
816-23
|
pubmed:meshHeading |
pubmed-meshheading:21046387-Angioplasty,
pubmed-meshheading:21046387-Aorta,
pubmed-meshheading:21046387-Cell Cycle,
pubmed-meshheading:21046387-Cell Proliferation,
pubmed-meshheading:21046387-Colony-Forming Units Assay,
pubmed-meshheading:21046387-Dose-Response Relationship, Radiation,
pubmed-meshheading:21046387-Endothelial Cells,
pubmed-meshheading:21046387-Maximum Tolerated Dose,
pubmed-meshheading:21046387-Microscopy, Fluorescence,
pubmed-meshheading:21046387-Radioisotopes,
pubmed-meshheading:21046387-Rhenium
|
pubmed:year |
2011
|
pubmed:articleTitle |
In vitro comparison of the antiproliferative effects of rhenium-186 and rhenium-188 on human aortic endothelial cells.
|
pubmed:affiliation |
Department of Diagnostic and Interventional Radiology, University Hospital of Tuebingen, Hoppe-Seyler-Str. 3 72076, Tuebingen, Germany. alexander.sauter@klinikum.uni-tuebingen.de
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro
|